<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Proteomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell Proteomics</journal-id>
<journal-id journal-id-type="hwp">mcprot</journal-id>
<journal-id journal-id-type="pmc">mcprot</journal-id>
<journal-id journal-id-type="publisher-id">MCP</journal-id>
<journal-title-group>
<journal-title>Molecular &amp; Cellular Proteomics : MCP</journal-title>
</journal-title-group>
<issn pub-type="ppub">1535-9476</issn>
<issn pub-type="epub">1535-9484</issn>
<publisher>
<publisher-name>The American Society for Biochemistry and Molecular Biology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29463595</article-id>
<article-id pub-id-type="pmc">5986238</article-id>
<article-id pub-id-type="publisher-id">RA117.000504</article-id>
<article-id pub-id-type="doi">10.1074/mcp.RA117.000504</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"></inline-graphic></sup></xref></article-title>
<alt-title alt-title-type="short">Proteotranscriptomic Profiling of Potential E6AP Targets</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gulati</surname>
<given-names>Twishi</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Cheng</given-names>
</name>
<xref ref-type="aff" rid="aff3">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caramia</surname>
<given-names>Franco</given-names>
</name>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raghu</surname>
<given-names>Dinesh</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paul</surname>
<given-names>Piotr J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goode</surname>
<given-names>Robert J. A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keam</surname>
<given-names>Simon P.</given-names>
</name>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Scott G.</given-names>
</name>
<xref ref-type="aff" rid="aff4">‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haupt</surname>
<given-names>Sue</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kleifeld</surname>
<given-names>Oded</given-names>
</name>
<xref ref-type="aff" rid="aff5">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schittenhelm</surname>
<given-names>Ralf B.</given-names>
</name>
<xref ref-type="aff" rid="aff3">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gamell</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
<xref ref-type="author-notes" rid="FN3">
<italic>
<sup>a</sup>
</italic>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haupt</surname>
<given-names>Ygal</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
<xref ref-type="aff" rid="aff6">‡‡</xref>
<xref ref-type="aff" rid="aff7">§§</xref>
<xref ref-type="aff" rid="aff8">¶¶</xref>
<xref ref-type="corresp" rid="cor1">‖‖</xref>
<xref ref-type="author-notes" rid="FN3">
<italic>
<sup>a</sup>
</italic>
</xref>
</contrib>
<aff id="aff1">From the ‡The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia; </aff>
<aff id="aff2">§Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; </aff>
<aff id="aff3">¶Monash Biomedical Proteomics Facility, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia; </aff>
<aff id="aff4">‖Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; </aff>
<aff id="aff5">**Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel; </aff>
<aff id="aff6">‡‡Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; </aff>
<aff id="aff7">§§Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia; </aff>
<aff id="aff8">¶¶Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">‖‖ To whom correspondence should be addressed:
<addr-line>Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.</addr-line> Tel.:
<phone>61-3-96565871</phone>; Fax:
<fax>61-3-96561411</fax>; E-mail:
<email>ygal.haupt@petermac.org</email>.</corresp>
<fn fn-type="other" id="FN3">
<p><italic><sup>a</sup></italic> Co-senior authorship.</p>
</fn>
<fn fn-type="con">
<p>Author contributions: T.G., O.K., R.B.S., C.G., and Y.H. designed research; T.G., C.H., D.R., and P.J.P. performed research; T.G., C.H., F.C., R.J.G., O.K., R.B.S., C.G., and Y.H. analyzed data; T.G. wrote the paper; S.P.K., S.G.W., and S.H. intellectual contribution; O.K., R.B.S., C.G., and Y.H. helped in preparation of manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>17</volume>
<issue>6</issue>
<fpage>1170</fpage>
<lpage>1183</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zjw00618001170.pdf"></self-uri>
<abstract>
<p>Prostate cancer is a common cause of cancer-related death in men. E6AP (E6-Associated Protein), an E3 ubiquitin ligase and a transcription cofactor, is elevated in a subset of prostate cancer patients. Genetic manipulations of E6AP in prostate cancer cells expose a role of E6AP in promoting growth and survival of prostate cancer cells <italic>in vitro</italic> and <italic>in vivo</italic>. However, the effect of E6AP on prostate cancer cells is broad and it cannot be explained fully by previously identified tumor suppressor targets of E6AP, promyelocytic leukemia protein and p27. To explore additional players that are regulated downstream of E6AP, we combined a transcriptomic and proteomic approach. We identified and quantified 16,130 transcripts and 7,209 proteins in castration resistant prostate cancer cell line, DU145. A total of 2,763 transcripts and 308 proteins were significantly altered on knockdown of E6AP. Pathway analyses supported the known phenotypic effects of E6AP knockdown in prostate cancer cells and in parallel exposed novel potential links of E6AP with cancer metabolism, DNA damage repair and immune response. Changes in expression of the top candidates were confirmed using real-time polymerase chain reaction. Of these, clusterin, a stress-induced chaperone protein, commonly deregulated in prostate cancer, was pursued further. Knockdown of E6AP resulted in increased clusterin transcript and protein levels <italic>in vitro</italic> and <italic>in vivo</italic>. Concomitant knockdown of E6AP and clusterin supported the contribution of clusterin to the phenotype induced by E6AP. Overall, results from this study provide insight into the potential biological pathways controlled by E6AP in prostate cancer cells and identifies clusterin as a novel target of E6AP.</p>
</abstract>
<kwd-group>
<kwd>Prostate cancer</kwd>
<kwd>Transcription*</kwd>
<kwd>SILAC</kwd>
<kwd>Ubiquitinases</kwd>
<kwd>Protein Identification*</kwd>
<kwd>Clusterin</kwd>
<kwd>E6AP</kwd>
<kwd>Proteomics</kwd>
<kwd>Transcriptomics</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Cancer Therapeutics CRC
</funding-source>
<award-id>Graduate Student Scholarship</award-id>
</award-group>
<award-group id="award2">
<funding-source>Australian Government Training Program
</funding-source>
<award-id>Graduate Student Scholarship</award-id>
</award-group>
<award-group id="award3">
<funding-source>
<institution-wrap>
<institution>Prostate Cancer Foundation (PCF)
</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000892</institution-id>
</institution-wrap>
</funding-source>
<award-id>Creativity Award</award-id>
</award-group>
<award-group id="award4">
<funding-source>
<institution-wrap>
<institution>Victorian Cancer Agency (VCA)
</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100008018</institution-id>
</institution-wrap>
</funding-source>
<award-id>Richard Pratt Fellowship in Prostate Cancer Research</award-id>
</award-group>
<award-group id="award5">
<funding-source>
<institution-wrap>
<institution>Cancer Council Victoria
</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100000951</institution-id>
</institution-wrap>
</funding-source>
<award-id>10851514</award-id>
</award-group>
<award-group id="award6">
<funding-source>Peter Mac Foundation
</funding-source>
<award-id>N/A</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>